CIK: 1507174 - Address: C/O Halozyme Therapeutics, Inc., 12390 El Camino Real, San Diego, CA 92130
36 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
10/16/24 18:53
10/15/24
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES.dm-1,07053.500-20-10174D
9/18/24 18:49
9/17/24
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES.dm-1,24962.450-20-10174D
8/21/24 18:03
8/20/24
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES.dm-1,22861.400-20-11168D
7/24/24 17:48
7/23/24
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES.dm-1,10055.000-20-11168D
6/20/24 16:17
6/18/24
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES.d-49449.430-10-6168D
5/22/24 17:24
5/21/24
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES.dm-90545.270-20-11168D
4/17/24 19:22
4/16/24
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES.dm-76838.420-20-11168D
3/13/24 17:22
3/12/24
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES.dm-83941.960-20-11157D
2/28/24 18:49
2/27/24
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES.dm-79539.750-20-11157D
1/18/24 16:07
1/16/24
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES.dm-72036.000-20-12152D
12/13/23 19:48
12/12/23
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES.dm-80040.010-20-12152D
11/16/23 16:18
11/14/23
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES.dm-78939.430-20-12152D
10/17/23 19:28
10/17/23
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES.d-36536.520-10-6152D
9/19/23 16:09
9/19/23
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES.d-39139.100-10-6152D
8/23/23 17:08
8/22/23
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES.d-42442.410-10-6152D
7/19/23 16:10
7/18/23
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES.d-40440.430-10-6152D
6/22/23 18:20
6/21/23
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES.d-36036.000-10-7142D
4/19/23 18:07
4/18/23
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES.d-36036.000-10-7142D
4/19/23 18:01
2/27/23
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES.ad-14849.550-3-2142D
2/28/23 16:59
2/27/23
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES-49549.550-10-7139D
2/21/23 19:05
2/16/23
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES.d-14249.260-3-2149D
2/17/23 06:29
2/15/23
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES.d-48448.390-10-6146D
1/18/23 19:07
1/17/23
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,CHIES-50550.460-10-7143D
12/13/22 18:09
12/13/22
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,ChieS-58758.670-10-6153D
11/16/22 19:25
11/15/22
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,ChieS-54154.130-10-6163D
10/1/21 19:32
10/1/21
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,ChieS.d-1,17639.930-29-17149D
7/6/21 17:19
7/1/21
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,ChieS.d-1,84245.700-40-23134D
4/1/21 19:44
4/1/21
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,ChieS.d-1,22142.560-29-19123D
3/1/21 20:06
3/1/21
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,ChieS-83945.810-18-13123D
12/21/20 18:01
12/21/20
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,ChieS-51142.580-12-9123D
11/20/20 18:25
11/20/20
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,ChieS-46538.760-12-8135D
10/20/20 16:53
10/20/20
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,ChieS-36530.430-12-8147D
9/21/20 19:30
9/21/20
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,ChieS-32326.910-12-7159D
8/20/20 16:21
8/20/20
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,ChieS-34028.300-12-7171D
7/20/20 18:33
7/20/20
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,ChieS-34829.010-12-6183D
5/21/20 16:11
5/20/20
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabarre Michael J.CAOSVP,ChieS.d-50923.800-21-11176D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact